版权说明：本文档由用户提供并上传，收益归属内容提供方，若内容存在侵权，请进行举报或认领
文档简介
BackgroundCRC:majorcauseofdeathanddiseaseBackgroundCRC:majorcauseof1BackgroundProcessesofcolorectalcarcinogenesislendthemselvestoscreeningBackgroundProcessesofcolorec2BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%Background28%3BackgroundColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsBackgroundColorectalcancerar4AimEvaluatethemultitargetstoolDNAtestasatoolforscreeningAimEvaluatethemultitarg5AimPrimaryaim:DNAtestinthedetectionofCRCSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)DNAtestVSAimPrimaryaim:DNAtest6MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsStudyPopulation:Asympt7Secondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comesAsubstantialproportionnevertested!digestivecancer,orinflammatoryboweldiseasepreviouscolonoscopy,bariumenema,CT,sigmoidoscopyundergonecolorectalresectionAdvancedprecancerouslesions:Advancedadenomashigh-gradedysplasiafamilyhistorySessileserratedpolypsmeasuring1cmormoreindiameterundergonecolorectalresectionStudyPopulation:Agesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyConclusionsSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemMethodsExcluded
personalhistory:colorectalneoplasia,digestivecancer,orinflammatoryboweldisease
previouscolonoscopy,bariumenema,CT,sigmoidoscopy
positiveresultsonfecalbloodtesting,rectalbleedingundergonecolorectalresectionfamilyhistorySecondaryaims:DNAtestinth8MethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterMethodsPrimaryandSecondaryO9aberrantlymethylatedBMP3andNDRG4promoterregionsmutantKRASimmunochemicalassayforhumanhemoglobinFITMultitargetstoolDNAtestaberrantlymethylatedBMP3and10Results127760.7%7.6%Results127760.7%7.6%11结肠癌英文文献抄读课件12ResultsResults13ResultsResults14ResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsFigure3.ReceiverOpera15ResultsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.ResultsMultitargetDNAtesting16ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.ConclusionsAstooltestcombin17TranslationalResearchAug.12,2014FDAApprovesCologuardFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestReceivedaproposedcove-ragememorandumfromtheCentersforMedicareandMedicaidServices(CMS)TranslationalResearchAug.12,18ProcessesofcolorectalcarcinogenesislendthemselvestoscreeningAdvancedprecancerouslesions:CRC,stagedeterminedwiththeuseoftheAJCCstagingsystem1190sitesundergonecolorectalresectionAdvancedprecancerouslesions:familyhistoryAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.positiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Aneasy-to-usescreen-ingtestEvaluatethemultitargetstoolDNAtestasatoolforscreeningColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsAdvancedadenomashigh-gradedysplasiaColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsStudyPopulation:PeopleataverageriskforcolorectalcancerAneasy-to-usescreen-ingtest599$Processesofcolorectalcarcin19结肠癌英文文献抄读课件20BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%Background28%21MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsStudyPopulation:Asympt22MethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterMethodsPrimaryandSecondaryO23ResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsFigure3.ReceiverOpera24ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.ConclusionsAstooltestcombin251190sitesAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemAsymptomaticpersonspositiveresultsonfecalbloodtesting,rectalbleedingdigestivecancer,orinflammatoryboweldiseaseAgesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesmeasure≥1cminthegreatestdimensionAdvancedadenomashigh-gradedysplasiaSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comespositiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesScheduledtoundergoscreeningcolonoscopyAdvancedprecancerouslesions:ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.undergonecolorectalresectionAdvancedadenomashigh-gradedysplasiaMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.undergonecolorectalresectionAsubstantialproportionnevertested!CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemwith≥25%villoushistologicfeaturesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Sessileserratedpolypsmeasuring1cmormoreindiameterConclusionsdigestivecancer,orinflammatoryboweldiseasepersonalhistory:colorectalneoplasia,Advancedprecancerouslesions:Colorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationspreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryaim:DNAtestinthedetectionofCRCEvaluatethemultitargetstoolDNAtestasatoolforscreeningCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesAsymptomaticpersonsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.positiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestpositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsfamilyhistoryAsubstantialproportionnevertested!Advancedprecancerouslesions:Processesofcolorectalcarcinogenesislendthemselvestoscreeningpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Advancedprecancerouslesions:Advancedprecancerouslesions:measure≥1cminthegreatestdimensionAdvancedadenomashigh-gradedysplasiaPrimaryandSecondaryOutcomesdigestivecancer,orinflammatoryboweldiseaseSessileserratedpolypsmeasuring1cmormoreindiameterpositiveresultsonfecalbloodtesting,rectalbleedingCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemundergonecolorectalresectionScreeningforCRCiscost-effectivewith≥25%villoushistologicfeaturesSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Sessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemAsymptomaticpersonsAsimple,noninvasivetestmightimproveclinicalout-comesTranslationalResearchpreviouscolonoscopy,bariumenema,CT,sigmoidoscopywith≥25%villoushistologicfeaturesAdvancedadenomashigh-gradedysplasiapositiveresultsonfecalbloodtesting,rectalbleedingmeasure≥1cminthegreatestdimensionPrimaryandSecondaryOutcomes1190sitesReceiverOpera26BackgroundCRC:majorcauseofdeathanddiseaseBackgroundCRC:majorcauseof27BackgroundProcessesofcolorectalcarcinogenesislendthemselvestoscreeningBackgroundProcessesofcolorec28BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%Background28%29BackgroundColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsBackgroundColorectalcancerar30AimEvaluatethemultitargetstoolDNAtestasatoolforscreeningAimEvaluatethemultitarg31AimPrimaryaim:DNAtestinthedetectionofCRCSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)DNAtestVSAimPrimaryaim:DNAtest32MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsStudyPopulation:Asympt33Secondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comesAsubstantialproportionnevertested!digestivecancer,orinflammatoryboweldiseasepreviouscolonoscopy,bariumenema,CT,sigmoidoscopyundergonecolorectalresectionAdvancedprecancerouslesions:Advancedadenomashigh-gradedysplasiafamilyhistorySessileserratedpolypsmeasuring1cmormoreindiameterundergonecolorectalresectionStudyPopulation:Agesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyConclusionsSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemMethodsExcluded
personalhistory:colorectalneoplasia,digestivecancer,orinflammatoryboweldisease
previouscolonoscopy,bariumenema,CT,sigmoidoscopy
positiveresultsonfecalbloodtesting,rectalbleedingundergonecolorectalresectionfamilyhistorySecondaryaims:DNAtestinth34MethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterMethodsPrimaryandSecondaryO35aberrantlymethylatedBMP3andNDRG4promoterregionsmutantKRASimmunochemicalassayforhumanhemoglobinFITMultitargetstoolDNAtestaberrantlymethylatedBMP3and36Results127760.7%7.6%Results127760.7%7.6%37结肠癌英文文献抄读课件38ResultsResults39ResultsResults40ResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsFigure3.ReceiverOpera41ResultsMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.ResultsMultitargetDNAtesting42ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.ConclusionsAstooltestcombin43TranslationalResearchAug.12,2014FDAApprovesCologuardFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestReceivedaproposedcove-ragememorandumfromtheCentersforMedicareandMedicaidServices(CMS)TranslationalResearchAug.12,44ProcessesofcolorectalcarcinogenesislendthemselvestoscreeningAdvancedprecancerouslesions:CRC,stagedeterminedwiththeuseoftheAJCCstagingsystem1190sitesundergonecolorectalresectionAdvancedprecancerouslesions:familyhistoryAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.positiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingMultitargetstoolDNAtestMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.Aneasy-to-usescreen-ingtestEvaluatethemultitargetstoolDNAtestasatoolforscreeningColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsCRC,stagedeterminedwiththeuseoftheAJCCstagingsystempositiveresultsonfecalbloodtesting,rectalbleedingAsymptomaticpersonsAdvancedadenomashigh-gradedysplasiaColorectalcancerarisesfromaccumulatedgeneticandepigeneticalterationsStudyPopulation:PeopleataverageriskforcolorectalcancerAneasy-to-usescreen-ingtest599$Processesofcolorectalcarcin45结肠癌英文文献抄读课件46BackgroundAsubstantialproportionnevertested!ScreeningforCRCiscost-effectiveAsimple,noninvasivetestmightimproveclinicalout-comes28%Background28%47MethodsStudyPopulation:2011.6-2012.1190sites
AsymptomaticpersonsAgesof50to84ataverageriskforCRCScheduledtoundergoscreeningcolonoscopyMethodsStudyPopulation:Asympt48MethodsPrimaryandSecondaryOutcomesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystem
Advancedprecancerouslesions:
Advancedadenomashigh-gradedysplasiawith≥25%villoushistologicfeaturesmeasure≥1cminthegreatestdimension
Sessileserratedpolypsmeasuring1cmormoreindiameterMethodsPrimaryandSecondaryO49ResultsFigure3.ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.ResultsFigure3.ReceiverOpera50ConclusionsAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.ConclusionsAstooltestcombin511190sitesAstooltestcombiningalteredhumanDNAandfecalhemoglobinshowedhighersensitivitythanacommercialFITforbothCRCandadvancedprecancerouslesions,althoughwithlowerspecificity.CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemAsymptomaticpersonspositiveresultsonfecalbloodtesting,rectalbleedingdigestivecancer,orinflammatoryboweldiseaseAgesof50to84ataverageriskforCRCpreviouscolonoscopy,bariumenema,CT,sigmoidoscopyPrimaryandSecondaryOutcomesmeasure≥1cminthegreatestdimensionAdvancedadenomashigh-gradedysplasiaSessileserratedpolypsmeasuring1cmormoreindiameterCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Asimple,noninvasivetestmightimproveclinicalout-comespositiveresultsonfecalbloodtesting,rectalbleedingpositiveresultsonfecalbloodtesting,rectalbleedingPrimaryandSecondaryOutcomesScheduledtoundergoscreeningcolonoscopyAdvancedprecancerouslesions:ReceiverOperatingCharacteristic(ROC)CurvesComparingDNATestingandFITfortheDetectionofColorectalCancerandAdvancedColorectalNeoplasia.undergonecolorectalresectionAdvancedadenomashigh-gradedysplasiaMultitargetDNAtestingdetectedclinicallysignificantlesionsmoreefficientlythanFIT.undergonecolorectalresectionAsubstantialproportionnevertested!CRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFDAApprovesCologuardCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemwith≥25%villoushistologicfeaturesCRC,stagedeterminedwiththeuseoftheAJCCstagingsystemFirstandOnlyStoolDNANoninvasiveColorectalCancerScreeningTestSecondaryaims:DNAtestinthedetectionofadvancedprecancerouslesionsandtocompareitwithacommerciallyavailablefecalimmunochemicaltest(FIT)Sessileserratedpolypsmeasuring1cmormoreindiameterConclusionsdigestivecancer,orinflammatoryboweldiseasepersonalhistory:colore
温馨提示
- 1. 本站所有资源如无特殊说明，都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等，如果需要附件，请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸，网页内容里面会有图纸预览，若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间，仅对用户上传内容的表现方式做保护处理，对用户上传分享的文档内容本身不做任何修改或编辑，并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容，请与我们联系，我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 药理学中的实验技术试题及答案
- 二手车评估与行业发展趋势试题及答案
- 统计学推断方法试题及答案咨询
- 2024年二手车金融服务的创新试题及答案
- 美容师行为规范考核试题及答案
- 宠物食品热量计算方法试题及答案
- 湖北省孝感市汉川市2022-2023学年三年级下学期英语期中试卷（含答案）
- 汽车维修工电子燃油喷射系统试题及答案
- 临床药物历史案例分析试题及答案
- 2024年美容行业的影响因素试题及答案
- 2024年电力交易员（中级工）职业鉴定理论考试题库-上（单选题）
- 门诊护士沟通培训课件
- 2025年企业招聘笔试题库及答案
- 2025年高中语文课内古诗文《蜀道难》《蜀相》联读教学设计
- GB/T 45290-2025乡村应急避难场所设计规范
- 签医废合同申请书
- 新疆防沙治沙生态建设可行性研究报告
- 手术室无菌技术原则和操作
- 护理阿尔茨海默病
- 《现代控制理论》全套课件(东北大学)
- 湖南省长沙市雅礼教育集团2022-2023学年八下期中数学试题（原卷版）
评论
0/150
提交评论